Literature DB >> 16148477

Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia.

Balázs Hauser1, Jochen Kick, Pierre Asfar, Ulrich Ehrmann, Maura Albicini, Josef Vogt, Ulrich Wachter, Uwe Bernd Brückner, Mitchell P Fink, Peter Radermacher, Hendrik Bracht.   

Abstract

OBJECTIVE: To investigate the systemic, pulmonary, and hepatosplanchnic hemodynamic and metabolic effects of delayed treatment with ethyl pyruvate in a long-term porcine model of hyperdynamic endotoxemia.
DESIGN: Prospective, randomized, controlled experimental study with repeated measures.
SETTING: Investigational animal laboratory.
SUBJECTS: Anesthetized, mechanically ventilated, and instrumented pigs.
INTERVENTIONS: After 12 hrs of continuous infusion of lipopolysaccharide and hydroxyethyl starch to keep mean arterial pressure >60 mm Hg, swine randomly received placebo (Ringer's solution; control group, n = 11) or ethyl pyruvate in lactated Ringer's solution (n = 8; 0.03 g.kg(-1) loading dose over 10 mins, thereafter 0.03 g.kg(-1)hr(-1) for 12 hrs).
MEASUREMENTS AND MAIN RESULTS: Whereas mean arterial pressure significantly decreased in control animals, mean arterial pressure was maintained at the baseline level in pigs treated with ethyl pyruvate. Global oxygen uptake was comparable, so that the trend toward a higher oxygen transport and the significantly higher mixed venous hemoglobin oxygen saturation resulted in a significantly lower oxygen extraction in the ethyl pyruvate group. Ethyl pyruvate reduced intrapulmonary venous admixture and resulted in significantly greater Pa(O2)/F(IO2) ratios. Despite comparable urine production in the two groups during the first 18 hrs of endotoxemia, ethyl pyruvate significantly increased diuresis during the last 6 hrs of the study. Lipopolysaccharide-induced systemic and regional venous metabolic acidosis was significantly ameliorated by ethyl pyruvate. Endotoxemia increased both blood nitrate + nitrite and isoprostane concentrations, and ethyl pyruvate attenuated the response of these markers of nitric oxide production and lipid peroxidation.
CONCLUSIONS: Ethyl pyruvate infusion resulted in improved hemodynamic stability and ameliorated acid-base derangements induced by chronic endotoxemia in pigs. Reduced oxidative stress and an decreased nitric oxide release probably contributed to these effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148477     DOI: 10.1097/01.ccm.0000178177.03979.ce

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

1.  Ethyl pyruvate inhibits hypoxic pulmonary vasoconstriction and attenuates pulmonary artery cytokine expression.

Authors:  Ben M Tsai; Tim Lahm; Eric D Morrell; Paul R Crisostomo; Jeffrey Poynter; Meijing Wang; Daniel R Meldrum
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

2.  Ethyl pyruvate prevents inflammatory responses and organ damage during resuscitation in porcine hemorrhage.

Authors:  WeiHong Dong; Bolin Cai; Geber Peña; Vadim Pisarenko; Gergely Vida; Danielle Doucet; Marlon Lee; Susan Sharpe; Qi Lu; Da-Zhong Xu; Laura Ramos; Edwin A Deitch; Luis Ulloa
Journal:  Shock       Date:  2010-08       Impact factor: 3.454

3.  Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats.

Authors:  Lu-Wen Wang; Li-Kun Wang; Hui Chen; Cheng Fan; Xun Li; Can-Ming He; Zuo-Jiong Gong
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

4.  Pyruvate-enriched resuscitation for shock.

Authors:  Robert T Mallet; Albert H Olivencia-Yurvati; Rolf Bünger
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

5.  Ethyl pyruvate modulates acute inflammatory reactions in human endothelial cells in relation to the NF-kappaB pathway.

Authors:  A-S Johansson; K Johansson-Haque; S Okret; J Palmblad
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

6.  Ethyl pyruvate for the treatment of acetaminophen intoxication: alternative to N-acetylcysteine?

Authors:  Florian Wagner; Pierre Asfar; Michael Georgieff; Peter Radermacher; Katja Wagner
Journal:  Crit Care       Date:  2012-02-20       Impact factor: 9.097

Review 7.  Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review.

Authors:  Guilang Zheng; Juanjuan Lyu; Jingda Huang; Dan Xiang; Meiyan Xie; Qiyi Zeng
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852

8.  Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release.

Authors:  Nils Wagner; Scott Dieteren; Niklas Franz; Kernt Köhler; Katharina Mörs; Luka Nicin; Julia Schmidt; Mario Perl; Ingo Marzi; Borna Relja
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

9.  Effects of ethyl pyruvate on leukocyte-endothelial interactions in the mesenteric microcirculation during early sepsis treatment.

Authors:  Ismael Francisco Mota Siqueira Guarda; Cristiano Jesus Correia; Ana Cristina Breithaupt-Faloppa; Sueli Gomes Ferreira; Ana Carolina Ramos Moreno; Marina Baquerizo Martinez; Mauricio Rocha-e-Silva; Paulina Sannomiya
Journal:  Clinics (Sao Paulo)       Date:  2015-07-01       Impact factor: 2.365

Review 10.  The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).

Authors:  Marcus Hollenbach
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.